Dr Ivan Gergel is an experienced and successful global pharmaceutical R&D executive. He has held senior leadership positions in several US corporations and overseen teams in the development, approval and commercialisation of numerous new medicines. Most recently, he was Chief Medical Officer and Head of Drug Development for Nektar Therapeutics, Inc. from 2014-2017.
From 2008-2014, Dr. Gergel was Executive Vice President and Chief Scientific Officer of Endo Health Solutions. He served in various roles at Forest Laboratories, Inc, from 1998-2008 including Senior Vice President of R&D and President of the Forest Research Institute. From 1989-1998, Dr Gergel worked in the UK and the US for SmithKline Beecham. He received his MD from the Royal Free Medical School, University of London, and his MBA from the Wharton School.
Dr Gergel is a member of the Royal College of Psychiatrists and a fellow of the Faculty of Pharmaceutical Medicine of the UK College of Physicians. He serves on the boards on Corium International Inc. and Realm Therapeutics. He has also served as a board member of PA BIO and of the PhRMA Foundation, and as a member of the Science and Regulatory Committee of PhRMA